Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Marleau

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cardiovascular Research|October 13, 2005
Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathiesSylvie Marleau, Mukandila Mulumba, Daniel Lamontagne, et al.
Biochimica Et Biophysica Acta|February 14, 2015
QRFP-43 inhibits lipolysis by preventing ligand-induced complex formation between perilipin A, caveolin-1, the catalytic subunit of protein kinase and hormone-sensitive lipase in 3T3-L1 adipocytesMukandila Mulumba, Riccarda Granata, Sylvie Marleau, et al.
Frontiers of Hormone Research|June 20, 2014
Potential peptides in atherosclerosis therapySylvie Marleau, Katia Mellal, David N Huynh, et al.
Immunology|January 26, 2008
Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in ratsCaroline Bélanger, Hanan Elimam, Julie Lefebvre, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2023
Therapeutic applications of nanoparticles targeting neutrophil and extracellular trapsNastaran Rezaei, Matthias Zadory, Samuel Babity, et al.
Cardiovascular Research|April 21, 2009
CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophagesKim Bujold, David Rhainds, Christian Jossart, et al.
Cardiovascular Research|March 7, 2009
The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammationDiala Harb, Kim Bujold, Maria Febbraio, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 7, 2007
Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failureMukandila Mulumba, Catia Céméus, Louis Dumont, et al.
Molecular Pharmaceutics|May 11, 2022
Optimization of a Liposomal DNase I Formulation with an Extended Circulating Half-LifeLesly Carolina Penaloza Arias, David N Huynh, Samuel Babity, et al.
The Biochemical Journal|June 5, 2004
Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking studyAnnie Demers, Normand McNicoll, Maria Febbraio, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cardiovascular Research|October 13, 2005
Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathiesSylvie Marleau, Mukandila Mulumba, Daniel Lamontagne, et al.
Biochimica Et Biophysica Acta|February 14, 2015
QRFP-43 inhibits lipolysis by preventing ligand-induced complex formation between perilipin A, caveolin-1, the catalytic subunit of protein kinase and hormone-sensitive lipase in 3T3-L1 adipocytesMukandila Mulumba, Riccarda Granata, Sylvie Marleau, et al.
Frontiers of Hormone Research|June 20, 2014
Potential peptides in atherosclerosis therapySylvie Marleau, Katia Mellal, David N Huynh, et al.
Immunology|January 26, 2008
Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in ratsCaroline Bélanger, Hanan Elimam, Julie Lefebvre, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2023
Therapeutic applications of nanoparticles targeting neutrophil and extracellular trapsNastaran Rezaei, Matthias Zadory, Samuel Babity, et al.
Cardiovascular Research|April 21, 2009
CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophagesKim Bujold, David Rhainds, Christian Jossart, et al.
Cardiovascular Research|March 7, 2009
The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammationDiala Harb, Kim Bujold, Maria Febbraio, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 7, 2007
Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failureMukandila Mulumba, Catia Céméus, Louis Dumont, et al.
Molecular Pharmaceutics|May 11, 2022
Optimization of a Liposomal DNase I Formulation with an Extended Circulating Half-LifeLesly Carolina Penaloza Arias, David N Huynh, Samuel Babity, et al.
The Biochemical Journal|June 5, 2004
Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking studyAnnie Demers, Normand McNicoll, Maria Febbraio, et al.
Pageof 5